Alexandria Real Estate Equities
ARE
#2377
Rank
โ‚น790.60 B
Marketcap
โ‚น4,594
Share price
-0.58%
Change (1 day)
-30.99%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -โ‚น53.48 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.85 Billion. In 2025 the company made an earning of -โ‚น94.48 Billion a decrease over its 2024 earnings that were of โ‚น66.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น53.48 Billion-43.4%
2025 -โ‚น94.48 Billion-242.13%
2024 โ‚น66.47 B96.11%
2023 โ‚น33.89 B-53.56%
2022 โ‚น72.99 B-3.96%
2021 โ‚น76.00 B-20.26%
2020 โ‚น95.31 B72.88%
2019 โ‚น55.13 B3.11%
2018 โ‚น53.46 B73.54%
2017 โ‚น30.80 B464.88%
2016 โ‚น5.45 B-77.32%
2015 โ‚น24.04 B36.31%
2014 โ‚น17.63 B-10.81%
2013 โ‚น19.77 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.010 T-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.970 T-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น867.17 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.023 T-1,839.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น110.69 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น915.84 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.99 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA